Andere Sprachen NAYA Biosciences, Inc.

Aktien

A3EJLW

US44984F4019

NAYA

Medizinische Versorgung

Verzögert Nasdaq Andere Börsenplätze 16:37:12 14.01.2025			% 5 Tage	% 1. Jan.
0.4950 ^USD	-1.00%		-48.44%	-38.89%

06.01.	Naya Biosciences kündigt die Entwicklung von Ny-500 an, einem neuartigen Ai-optimierten bifunktionalen Pd-1 X Vegf-Antikörper	CI
12.12.	NAYA Biosciences, Inc. gibt die Ernennung von Führungskräften und Vorstandsmitgliedern bekannt	CI

Andere Sprachen

NAYA Biosciences Announces Pricing of $9.5 Million Public Offering	13.01.
NAYA Biosciences Announces Development of NY-500, a Novel AI-Optimized PD-1 x VEGF Bifunctional Antibody	06.01.
Naya Biosciences Announces Development of Ny-500, A Novel Ai-Optimized Pd-1 X Vegf Bifunctional Antibody	06.01.
NAYA Biosciences, Inc. Announces Executive and Board Appointments	12.12.
NAYA Biosciences to Present Translational Insights to Support Phase I/IIa Clinical Trials for its GPC3-Targeting NK Engager Bispecific Antibody at the 2024 Annual Meeting of the Society for Immunotherapy of Cancer (SITC)	31.10.24
NAYA Biosciences Announces Initiation of Phase 1/2a Clinical Trial for its GPC3-targeted NK Engager Bispecific Antibody in Patients with Hepatocellular Carcinoma	24.10.24
NAYA Biosciences Announces Initiation of Phase 1/2a Clinical Trial for its GPC3-targeted NK Engager Bispecific Antibody in Patients with Hepatocellular Carcinoma	24.10.24
NAYA Biosciences, Inc.(NasdaqCM:NAYA) added to NASDAQ Composite Index	23.10.24
INVO Bioscience, Inc.(NasdaqCM:INVO) dropped from NASDAQ Composite Index	22.10.24
INVO Bioscience Confirms Corporate Name Change and New Trading Symbol in Connection with Its Recent Merger with NAYA Biosciences	21.10.24
INVO Bioscience and NAYA Biosciences Close Merger, Combined Company to Operate as NAYA Biosciences (NASDAQ: NAYA) Form 8 K	15.10.24
INVO Bioscience, Inc. Announces Board Changes	15.10.24
INVO BioScience, Inc. has Changed its Name to NAYA Biosciences, Inc	15.10.24
INVO BioScience, Inc. has Changed its Ticker to NAYA from INVO	15.10.24
INVO Bioscience Completes Merger With NAYA Biosciences Acquisition	14.10.24
INVO Bioscience and NAYA Biosciences Close Merger, Combined Company to Operate as NAYA Biosciences (NASDAQ: NAYA)	14.10.24
NAYA Biosciences completed the acquisition of INVO Bioscience, Inc. from Intracoastal Capital LLC and others in a reverse merger transaction.	14.10.24
Earnings Flash (INVO) INVO BIOSCIENCE Posts Q2 Loss $-0.62 Per Share	14.08.24
Earnings Flash (INVO) INVO BIOSCIENCE Posts Q2 Revenue $1.8M	14.08.24
INVO Reports Record Second Quarter 2024 Financial Results with 481% Revenue Growth and a $1.1 Million Improvement to Adjusted EBITDA	14.08.24
INVO Bioscience, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024	14.08.24
INVO Reports Record First Quarter 2024 Financial Results	15.05.24
INVO Bioscience, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	15.05.24
Exploring Emerging Companies with Key Developments Garnering Attention: INBS, INVO, VTAK, RCAT, GCTK	22.04.24
Top Premarket Decliners	18.04.24

Werden Sie Mitglied, um Zugang zu mehr Nachrichten zu erhalten.

100% kostenlose Registrierung

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen NAYA Biosciences, Inc.

Aktien

A3EJLW

US44984F4019

NAYA

Medizinische Versorgung

Andere Sprachen

Filter